Translational Medical Scientist

United States

Apply with AI Apply

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, HealthcareIndustries

Requirements

Candidates must possess a Ph.D. in Molecular Biology, Genomics, Cancer Biology, Genetics, or an equivalent field, along with a minimum of 2 years of relevant experience. A strong scientific background in oncology, including diagnostics and therapeutics, is required, with specific experience in ctDNA being preferred. Knowledge of cancer biology, molecular perspectives, and basic bioinformatics and genomics sequencing analysis techniques is necessary. Familiarity with data mining and statistical analysis tools like R, SQL, or Stata is a plus. Excellent communication, organizational, and interpersonal skills are essential for cross-functional teamwork.

Responsibilities

The Translational Medical Scientist will collaborate with clinicians, product managers, and key opinion leaders to translate product requirements into technical specifications for oncology products utilizing circulating tumor DNA. They will partner with molecular biologists, computational biologists, and statisticians to develop research strategies, and work with various departments to draft contracts and execute research projects. Responsibilities include performing genomic analysis to address scientific and clinical questions in oncology, translating findings to impact patient care, and leading internal efforts in oncology knowledge management. The role involves collaborating with external partners, including academics, biotechnology, and pharmaceutical companies, and communicating research results to academic researchers for publication in high-impact journals. Additionally, the scientist will work with business and biological teams to understand the research landscape and technology options.

Skills

Genomic data analysis

Circulating tumor DNA (ctDNA)

Oncology

Clinical data integration

Research strategy

Contract drafting

Scientific communication

Knowledge management

Collaboration

Problem-solving

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Austin, TexasHeadquarters

2004Year Founded

$149.9MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.

New Prospera Heart features may face slow adoption by healthcare providers.

Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.

Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.

Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.

AI integration enhances accuracy and speed of Natera's cfDNA analysis.

Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI

Try Jobo Free